Skip to main content
Log in

Follicle stimulating hormone - secreting pituitary adenoma: inappropriate secretion and effect of pulsatile luteinizing hormone releasing hormone analogue (buserelin) administration

  • Case Report
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

A patient with an FSH secreting pituitary adenoma is reported. Elevated FSH and serum free α-subunit (SU) with low levels of LH and testosterone (T) were found. Immunostaining showed the presence of α-SU, FSH-β and LH-β subunits. LHRH analogue (buserelin) was administered in a pulsatile manner, by portable computerized infusion pump sc for ten days. During the first 24 h of treatment FSH, LH (p < 0.001) and T (p < 0.01) rose significantly. Ten days later, the expected desensitization phenomenon did not occur, but further increases of T (8.4 ± 2.6, mean ± SD, vs 17.4 ± 4.1 nmol/l, p < 0.001) and FSH (58.9 ± 9.6 vs 70.7 ± 3.8 mlU/ml, p < 0.001) were registered. LH decreased (12.5 ± 2.4 vs 7.1 ± 0.6 mlU/ml, p < 0.001) at day 10, but remained higher than basal level (5.0 ± 0.6, p < 0.001). Free α-SU also rose (2.8 ± 0.4 vs 4.4 ± 1.7 mlU/ml, p < 0.001) after ten days of treatment. The chronic stimulatory effect of analogue on LH with a lack of desensitization suggests tumorous secretion despite a partially preserved negative feedback of testosterone. Low basal LH levels, in some patients with FSH secreting tumors may not be due to tumor mass effect, but rather may be the consequence of altered LH production and/or secretion by the tumor. Although bureselin may not have a therapeutic effect, it is of use in differential diagnosis of hypergonadotrophinemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kwekkeboom D.J., de Jong F.H., Lamberts S.W.J. Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: Relation to sex and effects of thyrotropin-releasing hormone, and bromocriptine. J. Clin. Endocrinol. Metab. 68: 1128, 1989.

    Article  PubMed  CAS  Google Scholar 

  2. Roman S.H., Goldstein M., Kourides I.A., Comite F., Bardin W.C., Krieger D.T. The luteinizing hormone releasing hormone (LHRH) agonist (D-Trp6-Pro9-NEt) LHRH increased rather than lowered LH and α-subunit levels in a patient with LH-secreting pituitary tumor. J. Clin. Endocrinol. Metab. 58: 313, 1984.

    Article  PubMed  CAS  Google Scholar 

  3. Klinanski A., Deutch P., Jameson J.L., Ridgway E.C., Crowley W.C., Zervas N.T. Luteinizing hormone (LH) and α-subunit secreting adenoma: Biosyntetic characteriterization and clinical studies. J. Clin. Endocrinol. Metab. 64: 536, 1987.

    Article  Google Scholar 

  4. Borges J.L.C., Ridgway E.C., Kovacs K., Rogol A.D., Thorner M.O. Follicle-stimulating hormone-secreting pituitary tumor with concomitant elevation of serum α-subunit levels. J. Clin. Endocrinol. Metab. 58: 937, 1984.

    Article  PubMed  CAS  Google Scholar 

  5. Friend J.N., Judge D.M., Sherman B.M., Santen R.J. FSH secreting pituitary adenomas: Stimulation and suppression studies in two patients. J. Clin. Endocinol. Metab. 43: 650, 1976.

    Article  CAS  Google Scholar 

  6. Cunningham G.R., Huckins C. An FSH and prolactin-secreting pituitary tumor: Pituitary dynamics and testicular histology. J. Clin. Endocrinol. Metab. 44: 248, 1977.

    Article  PubMed  CAS  Google Scholar 

  7. Klibanski A., Shupnik M.A., Bikkal H.A., Black P. McL., Kliman B., Zervas N.T. Dopaminergic regulation of α-subunit secretion and messenger ribonucleic acid levels in α-secreting pituitary tumors. J. Clin. Endocrinol. Metab. 65: 96, 1988.

    Article  Google Scholar 

  8. Demura R., Kubo J.O., Odagiri E., Demura H., Kitamura K., Shizume K., The significance of α-subunit as a tumor marker for gonadotropin-producing pituitary adenomas. J. Clin. Endocrinol. Metab. 63: 564, 1986.

    Article  PubMed  CAS  Google Scholar 

  9. Snyder P.J., Sterling F.H. Hypersecretion of LH and FSH by a pituitary adenoma. J. Clin. Endocrinol. Metab. 42: 544, 1976.

    Article  PubMed  CAS  Google Scholar 

  10. Snyder P.P.J., Muzyka R., Johnson J., Utiger R.D. Thyrotropin-releasing hormone provokes abnormal follicle-stimulating hormone (FSH) and luteinizing hormone responses in men who have pituitary adenomas and FSH hypersecretion. J. Clin. Endocrinol. Metab. 51: 744, 1980.

    Article  PubMed  CAS  Google Scholar 

  11. Whitcomb R.W., Sangha J.S., Schneyer A.L., Crowley W.F. Jr. Improved measurement of free alpha subunit of glycoprotein hormones by assay with use of monoclonal antibody. Clin. Chem. 34: 2022, 1988.

    PubMed  CAS  Google Scholar 

  12. Kourides I.O., Weintraub B.D., Rosen S.W., Ridgway E.C., Kliman B., Maloof F. Secretion of alpha subunit of glycoprotein hornones by pituitary adenomas. J. Clin. Endocrinol. Metab. 43: 97, 1976.

    Article  PubMed  CAS  Google Scholar 

  13. Peillon F., Bression B., Le Dafniet M., Brandi A.M., Li J.Y., Pagesy P., Birman P., Blumberg-Tick J., Michard M., Kujas M., Racadot J. Receptor studies in pituitary adenomas. Do they contribute to a better understanding of their pathogenesis? In: Landolt A.M., Heitz P.U., Zapf J., Girard J., Del Poso E. (Eds.), Advances in pituitary adenoma research. Pergamon Press, Oxford, 1988, p. 67.

    Google Scholar 

  14. Peterson R.E., Kourdies I.A., Horwith M., Darracot V. Jr, Saxena B.B., Fraser R.A.R. Luteinizing hormone- and α-subunit-secreting:pituitary tumor: Positive feedback of estrogen. J. Clin. Endocrinol. Metab. 52: 692, 1981.

    Article  PubMed  CAS  Google Scholar 

  15. Jameson L.L., Lindell C.M., Habener J.F. Gonadotropin and thyrotropin α- and β-subunit gene expression in normal and neplastic tissues characterised using specific messenger ribonucleic acid hybridization probes. J. Clin. Endocrinol. Metab. 64: 319, 1986.

    Article  Google Scholar 

  16. Duet M., Warnet A., Roche D., Seret D., Diop S.N., Lubetzki J. Gonadotropic adenoma with abnormal secretory pattern: Case report adenoma. In: Landolt A.M., Heitz P.U., Zapf J., Girard J., Del Pozo E. (Eds.), Advances in pituitary adenoma research. Pergamon Press., Oxford, 1988, p. 433.

    Google Scholar 

  17. Yuan Q.X., Swerdloff R.S., Bhasin S. Differential regulation of rat luteinizing hormone α- and β-subunits during the stimulatory and down-regulatory phases of gonadotropin-releasing hormone action. Endocrinology. 122: 504, 1988.

    Article  PubMed  CAS  Google Scholar 

  18. Vogel D.L., Magner J.A., Sherins R.J., Weintraub B.D. Biosynthesis, glycosylation and secretion of rat luteinizing hormone α- and β-subunits: Differential effects of orchiectomy and gonadotropin-releasing hormone. Endocrinology 119: 202, 1986.

    Article  PubMed  CAS  Google Scholar 

  19. Gharib S.D., Bowers S.M., Need L.R., Chin W.W. Regulation of rat luteinizing hormone subunit messenger ribonucleic acids by gonadal steroid hormones. J. Clin. Invest. 77: 582, 1986.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  20. Snyder P.J. Gonadotroph adenomas of the pituitary. J. Clin. Endocrinol. Metab. 6: 552, 1985.

    CAS  Google Scholar 

  21. Labrie F., Ferland L., Denizeau F., Beaulieu M. Sex steroids interact with dopamine at the hypothalamic and pituitary levels to modulate prolactin secretion. J. Steroid Biochem. 12: 323, 1980.

    Article  PubMed  CAS  Google Scholar 

  22. Berezin M., Olchovsky D., Pines A., Tadmor R., Lunenfeld B. Reduction of follicle-stimulating hormone (FSH) secretion in FSH producing pituitary adenoma by bromocriptine. J. Clin. Endocrinol. Metab. 59: 1220, 1984.

    Article  PubMed  CAS  Google Scholar 

  23. Vance M.L., Ridgway E.C., Thorner M.O. Follicle-stimulating hormone- and α-subunit-secreting pituitary tumor treated with bromocriptine. J. Clin. Endocrinol. Metab. 61: 580, 1985.

    Article  PubMed  CAS  Google Scholar 

  24. Sassolas G., Serusclat P., Claustrat B., Trouillas J., Merabet S., Cohen R., Souquet J.C. Plasma alpha-subunit levels during the treatment of pituitary adenomas with the somatostatin analog (SMS 201–995). Horm. Res. 29: 124, 1988.

    Article  PubMed  CAS  Google Scholar 

  25. Vas P., Croughs R.J.M., Thijssen J.W., van’t Verlaat J.W., van Ginkel LA. Response of luteinizing hormone secreting pituitary adenoma to a long acting somatostatin analogue. Acta Endocrinol. (Copenh.) 118: 587, 1988.

    Google Scholar 

  26. Reubi J.C., Lamberts S.W.J., Maurer R. Somatostatin receptors in normal and tumoral tissue. Horm. Res. 29: 65, 1988.

    Article  PubMed  CAS  Google Scholar 

  27. Cook D.M., Watkins S., Snyder P.J. Gonadotrophin-secreting adenomas masquerading as primary ovarian failure. Clin. Endocrinol. (Oxf.) 25: 729, 1986.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Damjanović, S., Micić, D., Popović, V. et al. Follicle stimulating hormone - secreting pituitary adenoma: inappropriate secretion and effect of pulsatile luteinizing hormone releasing hormone analogue (buserelin) administration. J Endocrinol Invest 14, 299–304 (1991). https://doi.org/10.1007/BF03346818

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03346818

Key-words

Navigation